{"type":"video","version":"1.0","html":"<iframe src=\"https://www.loom.com/embed/1879b4e38e0549a2ac5424d74bbdf442\" frameborder=\"0\" width=\"1920\" height=\"1440\" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>","height":1440,"width":1920,"provider_name":"Loom","provider_url":"https://www.loom.com","thumbnail_height":1440,"thumbnail_width":1920,"thumbnail_url":"https://cdn.loom.com/sessions/thumbnails/1879b4e38e0549a2ac5424d74bbdf442-2b7fcac5c413f581.gif","duration":1799.998,"title":"Advancements in Babesiosis Treatment and Drug Repurposing Strategies","description":"In this presentation, I discussed the challenges and strategies for treating babesiosis, particularly in immunocompromised patients. I shared two case studies highlighting the complexities of managing persistent babesiosis and the importance of drug dosing and scheduling. Notably, I emphasized the potential of repurposing malaria drugs, such as atovaquone and azithromycin, for effective treatment. I also presented data on the pharmacodynamics of these drugs, advocating for a higher dosing regimen to improve outcomes. I encourage you to consider these insights in your clinical practice and remain vigilant about the dosing strategies we employ."}